STOCK TITAN

Bank7 (BSVN) Financials

BSVN NASDAQ
Trailing 12 months to September 30, 2026
Revenue $96.5M +0.1% YoY
Net Income $41.3M -4.7% YoY
EPS (Diluted) $4.30 -5.1% YoY
Free Cash Flow $42.0M -7.1% YoY
Market Cap $604.9M as of Nov 19, 2026
Price / Sales 6.3x on $96.5M revenue, trailing 12 months to September 30, 2026
Price / Earnings 14.6x on $41.3M net income, trailing 12 months to September 30, 2026
Price / Book 2.2x on $273.7M equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 19, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q3 FY2026, filed Nov 9, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the BSVN SEC filings page.

Bank7 Corp. (BSVN) reported $96.5M in revenue over the twelve months to Sep 30, 2026, up 0.1% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI BSVN FY2025

Bank7’s earnings remain cash-backed, but FY2025 asset growth and weaker free cash flow show expansion consumed more capital than before.

Operating cash flow equaled 107.1% of net income, so accounting earnings still translated into cash. But free-cash-flow margin fell 9.2 percentage points to 43.0%, showing more cash was consumed after operations.

The balance sheet remains heavily liability-funded: liabilities were 87.2% of assets and total liabilities equaled 6.8x equity. Yet equity grew faster than liabilities, increasing 17.7% versus 12.2% and modestly improving the funding mix.

Revenue edged down 1.1% while assets expanded 12.9%, making balance-sheet expansion rather than top-line growth the main change in scale. Net income fell 5.8% while capital expenditures rose 12.9%, so the weaker cash yield reflects both softer earnings and heavier reinvestment.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Earnings Growth Capital Efficiency CreditQuality Stability 66 / 100
Financial Health Score (5 of 6 dimensions) 66/100
Scored as: Banks peer group

Scored against banks for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed: here 5 of 6, with the others left out rather than counted as zero. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Bank7 Corp.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Earnings
94

Earnings ranks banks on their return on assets, the profit made on every dollar of assets on the books, averaged over the last three fiscal years with the newest weighted most. Bank7 Corp. scores 94/100 on it among other banks.

Growth
22

Growth ranks banks on the yearly rate at which their net revenue, which is interest income and fee income less the interest they pay out, compounded across the last three fiscal years (the last two where the earliest reports none), counted in the currency each bank reports in. Bank7 Corp. scores 22/100 on it among other banks.

Capital
72

Bank7 Corp. funded 12.8% of its assets with shareholders' equity at the end of fiscal year 2025, holding $251.0M of equity against $2.0B of assets. Capital ranks banks on that cushion, and Bank7 Corp. scores 72/100 among other banks.

Efficiency
96

Efficiency measures what a bank spends running itself against the revenue that spending brings in, so a lower ratio is the better one. Bank7 Corp. scores 96/100 on it among other banks.

Credit Quality
n/a

Not available for Bank7 Corp., so it is left out of the overall score, which averages the 5 of 6 dimensions that can be computed.

Stability
45

Stability ranks banks on how far their net income strayed from its own average over the last five fiscal years, measured against the size of that average, and a smaller spread ranks higher. Bank7 Corp. scores 45/100 on it among other banks.

Piotroski F-Score Partial
3/6

Bank7 Corp. passes 3 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), the one computable operating efficiency signal (asset turnover improving) does not pass.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$23.4M
YoY-7.4%
QoQ+2.0%
5Y CAGR+11.0%

Bank7 Corp. generated $23.4M in revenue in Q3 2026. This represents a decrease of 7.4% from the same quarter a year earlier. Against the prior quarter it is up 2.0%.

Net Income
$10.2M
YoY-5.9%
QoQ+22.3%
5Y CAGR+10.2%

Bank7 Corp. reported $10.2M in net income in Q3 2026. This represents a decrease of 5.9% from the same quarter a year earlier. Against the prior quarter it is up 22.3%.

EPS (Diluted)
$1.06
YoY-6.2%
QoQ+21.8%
5Y CAGR+9.0%

Bank7 Corp. earned $1.06 per diluted share (EPS) in Q3 2026. This represents a decrease of 6.2% from the same quarter a year earlier. Against the prior quarter it is up 21.8%.

EBITDA

Not reported for Q3 2026.

Cash & Balance Sheet

Free Cash Flow
$14.4M
YoY-12.2%
QoQ+164.7%
5Y CAGR+20.8%

Bank7 Corp. generated $14.4M in free cash flow in Q3 2026, representing cash available after capex. This represents a decrease of 12.2% from the same quarter a year earlier. Against the prior quarter it is up 164.7%.

Cash & Debt
$277.2M
YoY+14.6%
QoQ+25.7%
5Y CAGR+6.1%

Bank7 Corp. held $277.2M in cash as of Q3 2026; no long-term debt figure is on record for that period.

Dividends Per Share
$0.30
YoY+11.1%
QoQ+11.1%
5Y CAGR+22.2%

Bank7 Corp. paid $0.30 per share in dividends in Q3 2026. This represents an increase of 11.1% from the same quarter a year earlier. Against the prior quarter it is up 11.1%.

Shares Outstanding
11M
YoY+13.5%
QoQ+12.7%
5Y CAGR+3.4%

Bank7 Corp. had 11M shares outstanding in Q3 2026. This represents an increase of 13.5% from the same quarter a year earlier. Against the prior quarter it is up 12.7%.

Margins & Returns

Net Margin
43.7%
YoY+0.7pp
QoQ+7.2pp
5Y change-1.6pp

Bank7 Corp.'s net profit margin was 43.7% in Q3 2026, showing the share of revenue converted to profit. This is up 0.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 7.2 percentage points.

Return on Equity
3.7%
YoY-0.8pp
QoQ+0.6pp
5Y change-1.4pp

Bank7 Corp.'s quarterly ROE was 3.7% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is down 0.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.6 percentage points.

Gross Margin

Not reported for Q3 2026.

Operating Margin

Not reported for Q3 2026.

Capital Allocation

Share Buybacks
$141K
YoY+1466.7%
QoQn/m

Bank7 Corp. spent $141K on share buybacks in Q3 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 1466.7% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Capital Expenditures
$1.5M
YoY+603.7%
QoQ-26.5%
5Y CAGR+78.1%

Bank7 Corp. invested $1.5M in capex in Q3 2026, funding long-term assets and infrastructure. This represents an increase of 603.7% from the same quarter a year earlier. Against the prior quarter it is down 26.5%.

R&D Spending

Not reported for Q3 2026.

BSVN Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BSVN quarterly income statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Revenue$23.4M-7.4%$22.9M-6.3%$26.2M+15.8%$24.1M-0.1%$25.2M+1.4%$24.4M+0.2%$22.6M-5.9%$24.1M-14.0%
Interest Expense$9.6M-9.9%$9.0M-10.2%$9.6M-0.1%$10.6M-0.4%$10.7M-12.9%$10.0M-10.4%$9.6M-14.9%$10.6M-4.6%
Income Tax$3.4M+2.1%$2.7M-25.9%$3.8M+13.0%$3.4M-6.5%$3.3M-10.1%$3.6M-3.5%$3.4M-6.1%$3.6M+633.9%
Net Income$10.2M-5.9%$8.3M-24.8%$12.0M+16.2%$10.8M-2.9%$10.8M-7.9%$11.1M-3.6%$10.3M-8.4%$11.1M+939.2%
EPS (Basic)$1.07-7.0%$0.88-25.4%$1.26+14.5%$1.14-4.2%$1.15-8.7%$1.18-5.6%$1.10-9.8%$1.19+891.7%
EPS (Diluted)$1.06-6.2%$0.87-25.0%$1.25+15.7%$1.12-3.4%$1.13-8.9%$1.16-5.7%$1.08-10.7%$1.16+954.5%
Diluted Shares (Avg)10M+0.4%10M+0.6%10M+0.5%N/A10M+1.0%10M+1.9%10M+2.5%N/A

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA.

BSVN Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BSVN quarterly balance sheet
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Total Assets$2.0B+6.1%$1.9B+4.2%$1.9B+8.9%$2.0B+12.9%$1.9B+8.7%$1.8B+9.1%$1.8B+0.6%$1.7B-1.8%
Cash & Equivalents$277.2M+14.6%$220.6M+0.8%$246.7M+2.5%$244.6M+4.5%$241.8M+29.5%$218.8M+4.2%$240.6M+24.5%$234.2M+29.4%
Goodwill$11.2M0.0%$11.2M0.0%$11.2M0.0%$11.2M+32.5%$11.2M+32.5%$11.2M+32.5%$11.2M+32.5%$8.5M0.0%
Total Liabilities$1.7B+5.1%$1.6B+2.7%$1.7B+7.8%$1.7B+12.2%$1.6B+7.4%$1.6B+7.5%$1.6B-1.9%$1.5B-4.7%
Total Equity$273.7M+13.2%$266.3M+14.9%$259.8M+17.2%$251.0M+17.7%$241.7M+18.4%$231.9M+21.5%$221.7M+22.9%$213.2M+25.2%
Retained Earnings$172.3M+21.8%$164.9M+23.8%$159.1M+28.0%$149.7M+28.7%$141.5M+31.7%$133.2M+36.1%$124.3M+40.8%$116.3M+47.3%

Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Current Liabilities, Non-Current Liabilities, Long-Term Debt.

BSVN Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BSVN quarterly cash flow statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Cash Flow$15.9M-4.3%$7.5M-20.7%$16.6M+51.4%$9.1M-30.8%$16.6M+24.4%$9.4M+16.0%$11.0M-46.2%$13.1M-19.0%
Depreciation & Amortization$304K+4.8%$290K+0.3%$290K+15.5%$289K+17.5%$290K+14.2%$289K+10.3%$251K-14.9%$246K-25.2%
Stock-Based CompensationN/AN/A$659K+1.1%N/AN/AN/A$652K+7.9%N/A
Capital Expenditures$1.5M+603.7%$2.0M+220.5%$2.5M-11.2%$1.1M-17.0%$214K-65.1%$639K-60.3%$2.8M+319.6%$1.3M+462.9%
Free Cash Flow$14.4M-12.2%$5.4M-38.2%$14.2M+72.8%$8.0M-32.3%$16.4M+28.8%$8.8M+34.8%$8.2M-58.6%$11.8M-26.0%
Investing Cash Flow-$39.9Mn/m$2.5Mn/m$18.6Mn/m-$67.4M-250.0%-$34.1Mn/m-$71.8M-165.7%-$37.3M-812.3%$44.9Mn/m
Financing Cash Flow$80.6M+99.3%-$36.1M-189.0%-$33.1M-201.5%$61.2Mn/m$40.4M-4.9%$40.6Mn/m$32.6Mn/m-$10.5Mn/m
Dividends Paid$2.6M+13.3%$2.6M+13.3%$2.6M+13.4%$2.6M+13.8%$2.3M+16.7%$2.3M+17.0%$2.3M+16.7%$2.2M+16.0%
Share Buybacks$141K+1466.7%$0-100.0%$1.2M+15.8%$251K+4.1%$9K+28.6%$2K+100.0%$1.0M+143.4%$241K+65.1%

BSVN Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BSVN quarterly financial ratios
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Net Margin43.7%+0.7pp36.4%-9.0pp45.9%+0.2pp44.7%-1.3pp43.0%-4.3pp45.4%-1.8pp45.7%-1.3pp46.0%+42.2pp
Return on Equity3.7%-0.8pp3.1%-1.7pp4.6%0.0pp4.3%-0.9pp4.5%-1.3pp4.8%-1.3pp4.7%-1.6pp5.2%+4.6pp
Return on Assets0.5%-0.1pp0.4%-0.2pp0.6%0.0pp0.5%-0.1pp0.6%-0.1pp0.6%-0.1pp0.6%-0.1pp0.6%+0.6pp
Liabilities-to-Equity6.33-0.5x6.19-0.7x6.49-0.6x6.82-0.3x6.82-0.7x6.92-0.9x7.06-1.8x7.16-2.2x
Asset Turnover0.010.0x0.010.0x0.010.0x0.010.0x0.010.0x0.010.0x0.010.0x0.010.0x
FCF Margin61.7%-3.4pp23.8%-12.3pp54.1%+17.9pp33.1%-15.7pp65.0%+13.8pp36.0%+9.3pp36.3%-46.1pp48.8%-7.9pp

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, Debt-to-Equity.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Bank7 Corp. BSVN FY2025 $96.4M $43.1M 44.7% $604.9M 66/100
Carter Bankshares, Inc. CARE FY2025 $153.2M $31.4M 20.5% $627.2M 35/100
Unity Bancorp UNTY FY2025 $131.8M $58.0M 44.0% $574.5M 75/100
Southern First Bancshares, Inc. SFST FY2025 $118.1M $30.4M 25.7% $549.5M 42/100
Red River Bancshares, Inc. RRBI FY2025 $125.5M $42.8M 34.1% $674.2M 67/100
Third Coast Bancshares, Inc. TCBX FY2025 $208.9M $66.3M 31.7% $637.7M 54/100

Frequently Asked Questions

Bank7 Corp. (BSVN) reported $96.4M in total revenue for fiscal year 2025. This represents a -1.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Bank7 Corp. (BSVN) revenue declined by 1.1% year-over-year, from $97.4M to $96.4M in fiscal year 2025.

Yes, Bank7 Corp. (BSVN) reported a net income of $41.3M over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net income of $43.1M, with a net profit margin of 44.7%.

Bank7 Corp. (BSVN) reported diluted earnings per share of $4.50 for fiscal year 2025. This represents a -7.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Bank7 Corp. (BSVN) had a net profit margin of 44.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, Bank7 Corp. (BSVN) paid $1.02 per share in dividends during fiscal year 2025.

Bank7 Corp. (BSVN) has a return on equity of 17.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Bank7 Corp. (BSVN) generated $41.4M in free cash flow during fiscal year 2025. This represents a -18.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Bank7 Corp. (BSVN) generated $46.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Bank7 Corp. (BSVN) had $2.0B in total assets as of fiscal year 2025, including both current and long-term assets.

Bank7 Corp. (BSVN) invested $4.7M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, Bank7 Corp. (BSVN) spent $1.3M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Bank7 Corp. (BSVN) had 10M shares outstanding as of fiscal year 2025.

Bank7 Corp. (BSVN) had a liabilities-to-equity ratio of 6.82 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.

Bank7 Corp. (BSVN) had a return on assets of 2.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Bank7 Corp. (BSVN) trades at 14.6x earnings, its market capitalization divided by $41.3M net income, trailing 12 months to September 30, 2026. The market capitalization is $604.9M as of Nov 19, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Bank7 Corp. (BSVN) trades at 6.3x sales, its market capitalization divided by $96.5M revenue, trailing 12 months to September 30, 2026. The market capitalization is $604.9M as of Nov 19, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Bank7 Corp. (BSVN) has a Piotroski F-Score of 3 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Bank7 Corp. (BSVN) scores 66 out of 100 on our Financial Health Score, indicating strong standing within its banks peer group. The score is the average of six dimensions (Earnings, Growth, Capital, Efficiency, Credit Quality, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. For Bank7 Corp. it averages the 5 of 6 dimensions that can be computed; the others are left out rather than counted as zero. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top